TrialOncogene2025

Integration of germline pharmacogenomic burden to predict fluoropyrimidine-related toxicity - A secondary analysis of the PREPARE trial.

Elena De Mattia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.